27012 Federal Register / Vol. 83, No. 112 / Monday, June 11, 2018 / Notices 

information gathered by the Department 

of Health and Human Services and the 

Department of Justice with regard to 

safety, efficacy, and abuse potential of 

drugs or other substances, and 

recommends actions to be taken by the 

Department of Health and Human 

Services with regard to the marketing, 

investigation, and control of such drugs 

or other substances. 

The Committee shall consist of a core 

of 11 voting members including the 

Chair. Members and the Chair are 

selected by the Commissioner or 

designee from among authorities 

knowledgeable in the fields of risk 

communication, risk management, drug 

safety, medical, behavioral, and 

biological sciences as they apply to risk 

management, and drug abuse. Members 

will be invited to serve for overlapping 

terms of up to 4 years. Almost all nonFederal members of this committee 

serve as Special Government 

Employees. The core of voting members 

may include one technically qualified 

member, selected by the Commissioner 

or designee, who is identified with 

consumer interests and is recommended 

by either a consortium of consumeroriented organizations or other 

interested persons. In addition to the 

voting members, the Committee may 

include one non-voting member who is 

identified with industry interests. 

Further information regarding the 

most recent charter and other 

information can be found at https://

www.fda.gov/AdvisoryCommittees/ 

CommitteesMeetingMaterials/Drugs/ 

DrugSafetyandRiskManagement

AdvisoryCommittee/default.htm or by 

contacting the Designated Federal 

Officer (see FOR FURTHER INFORMATION

CONTACT). In light of the fact that no 

change has been made to the committee 

name or description of duties, no 

amendment will be made to 21 CFR 

14.100. 

This document is issued under the 

Federal Advisory Committee Act (5 

U.S.C. app.). For general information 

related to FDA advisory committees, 

please check https://www.fda.gov/ 

AdvisoryCommittees/default.htm. 

Dated: June 5, 2018. 

Leslie Kux, 

Associate Commissioner for Policy. 

[FR Doc. 2018–12442 Filed 6–8–18; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Council on Graduate Medical 

Education 

AGENCY: Health Resources and Service 

Administration (HRSA), Department of 

Health and Human Services (HHS). 

ACTION: Notice of Advisory Council 

meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, this 

notice announces a public meeting of 

the Council on Graduate Medical 

Education (COGME). This notice is 

being published less than 15 days prior 

to the meeting date due to unforeseen 

administrative delays. 

DATES: Wednesday, June 20, 2018, from 

8:30 a.m. to 5:00 p.m. ET, and Thursday, 

June 21, 2018, from 8:30 a.m. to 2:00 

p.m. ET. 

ADDRESSES: This meeting is an in person 

meeting and will offer virtual access 

through teleconference and webinar. 

The address for the meeting is 5600 

Fishers Lane, Rockville, Maryland 

20857. 

• The conference call-in number is 1– 

800–619–2521; passcode: 9271697. 

• The webinar link is https://

hrsa.connectsolutions.com/cogme. 

FOR FURTHER INFORMATION CONTACT: 

Kennita R. Carter, MD, Designated 

Federal Official, Division of Medicine 

and Dentistry, Bureau of Health 

Workforce, HRSA, Address: 5600 

Fishers Lane, 15N–116, Rockville, 

Maryland 20857; (2) call 301–945–3505; 

or (3) send an email to KCarter@

hrsa.gov. 

SUPPLEMENTARY INFORMATION: 

Background: COGME provides advice 

and recommendations to the Secretary 

of HHS and to Congress on a range of 

issues, including: The nature and 

financing of medical education training; 

the development of performance 

measures and longitudinal evaluation 

methods of medical education 

programs; foreign medical school 

graduates; and the supply and 

distribution of the physician workforce 

in the United States, including any 

projected shortages or excesses. COGME 

submits reports to the Secretary of HHS; 

the Senate Committee on Health, 

Education, Labor, and Pensions; and the 

House of Representatives Committee on 

Energy and Commerce. 

Agenda: During the meeting, the 

COGME members will discuss the 

strategic directions of the Council and 

issues related to physician workforce 

development and graduate medical 

education, leading to selection a topic 

for its 24th Report to Congress. An 

agenda will be available on the COGME 

website https://www.hrsa.gov/ 

advisorycommittees/bhpradvisory/ 

COGME/ prior to the meeting. Please 

note that agenda items are subject to 

change as priorities dictate. 

Public Participation: Members of the 

public will have the opportunity to 

provide comments. Public participants 

may submit written statements in 

advance of the scheduled meeting. Oral 

comments will be honored in the order 

they are requested and may be limited 

as time allows. Requests to provide 

written statements or make oral 

comments to the COGME should be sent 

to Dr. Kennita R. Carter. 

Since this meeting is held in a Federal 

government building, attendees must go 

through a security check to enter the 

building. Non-U.S. Citizen attendees 

must notify HRSA of their planned 

attendance at least 10 workdays prior to 

the meeting in order to facilitate their 

entry into the building. All attendees are 

required to present government-issued 

identification prior to entry. Individuals 

who plan to participate and require 

special assistance, such as sign language 

interpretation or other reasonable 

accommodations, should notify Dr. 

Kennita Carter, using the address and 

phone number above at least 10 

business days prior to the meeting. 

Amy P. McNulty, 

Acting Director, Division of the Executive 

Secretariat. 

[FR Doc. 2018–12512 Filed 6–8–18; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Request for Information (RFI): Input on 

Report From Council of Councils on 

Assessing the Safety of Relocating AtRisk Chimpanzees 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: The National Institutes of 

Health (NIH) is informing the research 

community and other interested parties 

that it received from the NIH Council of 

Councils the report of its Working 

Group on Assessing the Safety of 

Relocating At-Risk Chimpanzees, and 

the agency will consider 

recommendations contained in the 

report (see https://dpcpsi.nih.gov/sites/ 


daltland on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 83, No. 112 / Monday, June 11, 2018 / Notices 27013 

default/files/CoC_May_2018_WG_

Report_508.pdf). The NIH invites public 

comment in response to this Request for 

Information (RFI). 

DATES: This Request for Information is 

open for public comment for a period of 

60 days. Comments must be submitted 

by August 10, 2018 to ensure 

consideration. 

ADDRESSES: Comments must be 

submitted electronically using the webbased form available at https://

grants.nih.gov/grants/rfi/rfi.cfm?ID=72. 

FOR FURTHER INFORMATION CONTACT: 

Please direct all inquiries to the 

Division of Program Coordination, 

Planning, and Strategic Initiatives at 

dpcpsi@od.nih.gov. 

SUPPLEMENTARY INFORMATION: 

Background: In 2015, the NIH decided 

that all NIH-owned chimpanzees 

residing outside of the federal 

chimpanzee sanctuary system were 

eligible for retirement and relocation to 

the sanctuary. This decision was based 

on several converging efforts: 

• A 2011 report by the Institute of 

Medicine (IOM) that stated the use of 

chimpanzees in research has become 

‘‘largely unnecessary’’ and 

recommended approaches to minimize 

their use in federally funded research. 

• A 2013 report from an earlier NIH 

Council of Councils working group that 

made recommendations to the NIH on 

implementing the IOM principles and 

guidelines and placement of NIH-owned 

or -supported chimpanzees. 

• A 2015 announcement by the U.S. 

Fish and Wildlife Service, designating 

all captive chimpanzees as endangered, 

thereby conferring specific protections 

under the Endangered Species Act. 

• Observations by the NIH of a 

significantly reduced demand for 

chimpanzees for research. 

A priority for the NIH, relocation of 

the chimpanzees to the sanctuary 

proceeds according to a retirement plan 

prepared by the NIH. The retirement 

plan, as well as the November 2015 NIH 

announcement, state that chimpanzees 

will be retired to the sanctuary once 

space becomes available and on a 

timescale that considers the health, 

welfare, and social grouping of 

individual chimpanzees. However, 

many of these chimpanzees have agerelated ailments that can increase their 

risk of severe adverse events during the 

transfer and relocation process. 

On January 26, 2018, the NIH Council 

of Councils established a Working 

Group on Assessing the Safety of 

Relocating At-Risk Chimpanzees to 

provide advice and recommendations to 

the Council on factors to be considered 

by attending veterinarian staff when 

deciding whether to relocate NIHowned or -supported at-risk 

chimpanzees to the federal sanctuary 

system. On May 18, 2018, the working 

group submitted the report to the NIH 

Council of Councils, which 

subsequently approved the report and 

transmitted it to the NIH for 

consideration. 

Information Requested: The NIH is 

seeking input on the recommendations 

(see https://dpcpsi.nih.gov/sites/default/ 

files/CoC_May_2018_WG_Report_

508.pdf) from the biomedical research 

community, including foundations, 

scientific societies, government and 

regulatory agencies, industry, NIH 

grantee institutions, and from other 

members of the public. Responders are 

free to address any or all 

recommendations. 

How to Submit a Response: All 

comments must be submitted 

electronically to https://grants.nih.gov/ 

grants/rfi/rfi.cfm?ID=72. Comments 

must pertain to the category for which 

feedback is requested, conform to the 

word limit indicated, and be submitted 

by the specified due date. You will see 

an electronic confirmation 

acknowledging receipt of your response 

but will not receive individualized 

feedback on any suggestions. 

Response to this RFI is voluntary. No 

basis for claims against the U.S. 

Government shall arise as a result of a 

response to this RFI or from the 

Government’s use of such information. 

Please note that the Government will 

not pay for response preparation or for 

the use of any information contained in 

the response. The NIH may make all 

responses available, including name of 

the responder, without notifying the 

respondent. In addition, the NIH may 

prepare and make available a summary 

of all input received which is 

responsive to this RFI. 

Dated: June 4, 2018. 

Lawrence A. Tabak, 

Deputy Director, National Institutes of Health. 

[FR Doc. 2018–12458 Filed 6–8–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Agency Information Collection 

Activities: Homeland Security 

Acquisition Regulation (HSAR) Various 

Forms 

AGENCY: Office of the Chief Procurement 

Officer, Department of Homeland 

Security (DHS). 

ACTION: 30-Day notice and request for 

comments; Extension of a Currently 

Approved Collection, 1600–0002. 

SUMMARY: The DHS Office of the Chief 

Procurement Officer will submit the 

following Information Collection 

Request (ICR) to the Office of 

Management and Budget (OMB) for 

review and clearance in accordance 

with the Paperwork Reduction Act of 

1995. The purpose of the information 

collected is to ensure proper closing of 

physically complete contracts. The 

information will be used by DHS 

contracting officers to ensure 

compliance with terms and conditions 

of DHS contracts and to complete 

reports required by other Federal 

agencies such as the General Services 

Administration (GSA) and the 

Department of Labor (DOL). If this 

information is not collected, DHS could 

inadvertently violate statutory or 

regulatory requirements and DHS’s 

interests concerning inventions and 

contractors’ claims would not be 

protected. DHS previously published 

this ICR in the Federal Register on 

Tuesday, March 6, 2018 for a 60-day 

public comment period. Six unrelated 

comments were received by DHS. The 

purpose of this notice is to allow an 

additional 30 days for public comments. 

DATES: Comments are encouraged and 

will be accepted until July 11, 2018. 

This process is conducted in accordance 

with 5 CFR 1320.1. 

ADDRESSES: Interested persons are 

invited to submit written comments on 

the proposed information collection to 

the Office of Information and Regulatory 

Affairs, Office of Management and 

Budget. Comments should be addressed 

to OMB Desk Officer, Department of 

Homeland Security and sent via 

electronic mail to dhsdeskofficer@

omb.eop.gov. 

SUPPLEMENTARY INFORMATION: This 

information collection is associated 

with the forms listed below and is 

necessary to implement applicable parts 

of the HSAR (48 CFR Chapter 30). There 

are four forms under this collection of 

information request that are used by 

offerors, contractors, and the general 

public to comply with requirements in 

contracts awarded by DHS. The 

information collected is used by 

contracting officers to ensure 

compliance with terms and conditions 

of DHS contracts. 

The forms are as follows: 

1. DHS Form 0700–01, Cumulative 

Claim and Reconciliation Statement 

(see (HSAR) 48 CFR 3004.804– 

507(a)(3) 


daltland on DSKBBV9HB2PROD with NOTICES